171 related articles for article (PubMed ID: 10971481)
1. The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom.
Kirby B; Lyon CC; Griffiths CE; Chalmers RJ
Clin Exp Dermatol; 2000 Jun; 25(4):265-8. PubMed ID: 10971481
[TBL] [Abstract][Full Text] [Related]
2. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and methotrexate therapy for psoriasis.
Hughes R; Harries M; Chalmers RJ; Kirby B
J Am Acad Dermatol; 2006 Aug; 55(2):366-7. PubMed ID: 16844540
[No Abstract] [Full Text] [Related]
4. Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists.
Gyulai R; Bagot M; Griffiths CEM; Luger T; Naldi L; Paul C; Puig L; Kemény L
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):224-231. PubMed ID: 24731093
[TBL] [Abstract][Full Text] [Related]
5. Does daily folic acid supplementation reduce methotrexate efficacy?
Cline A; Jorizzo JL
Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447631
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
7. Folic acid - Who does what with methotrexate?
Randhawa A; Blair R; Wylie G
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e469-e470. PubMed ID: 28423206
[No Abstract] [Full Text] [Related]
8. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
[TBL] [Abstract][Full Text] [Related]
9. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
Prey S; Paul C
Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.
Tournier A; Khemis A; Maccari F; Reguiai Z; Bégon E; Fougerousse AC; Amy de la Breteque M; Beneton N; Parier J; Boyé T; Avenel-Audran M; Girard C; Pallure V; Perrot JL; Bastien M; Mahé E; Beauchet A;
Ann Dermatol Venereol; 2019 Feb; 146(2):106-114. PubMed ID: 30704943
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate: improving safety profile.
Grills C; Burge S
Australas J Dermatol; 2006 Aug; 47(3):178-81. PubMed ID: 16866998
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation.
Menting SP; Dekker PM; Limpens J; Hooft L; Spuls PI
Acta Derm Venereol; 2016 Jan; 96(1):23-8. PubMed ID: 25721372
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate for psoriasis: current European practice. A postal survey.
Boffa MJ
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):196-202. PubMed ID: 15752290
[TBL] [Abstract][Full Text] [Related]
14. Folate supplementation during methotrexate therapy for patients with psoriasis.
Strober BE; Menon K
J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
[TBL] [Abstract][Full Text] [Related]
15. Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.
Baran W; Batycka-Baran A; Zychowska M; Bieniek A; Szepietowski JC
Expert Opin Drug Saf; 2014 Aug; 13(8):1015-21. PubMed ID: 24972718
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
[TBL] [Abstract][Full Text] [Related]
17. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS;
JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160
[TBL] [Abstract][Full Text] [Related]
18. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis.
Duhra P
J Am Acad Dermatol; 1993 Mar; 28(3):466-9. PubMed ID: 8445064
[TBL] [Abstract][Full Text] [Related]
19. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.
Barker J; Horn EJ; Lebwohl M; Warren RB; Nast A; Rosenberg W; Smith C;
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):758-64. PubMed ID: 21198946
[TBL] [Abstract][Full Text] [Related]
20. A simple intervention to improve safety in methotrexate prescribing.
Birnie AJ; Littlewood SM
Australas J Dermatol; 2007 May; 48(2):134. PubMed ID: 17535208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
